Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Norvège91
J. P. Larsen17
Norvège Sauf J. P. Larsen" 74
J. P. Larsen Sauf Norvège" 0
Norvège Et J. P. Larsen 17
Norvège Ou J. P. Larsen 91
Corpus4598
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 17.
Ident.Authors (with country if any)Title
000510 H. Vefring [Norvège] ; K. Haugarvoll [Norvège] ; O. Tysnes [Norvège] ; J. P. Larsen [Norvège] ; M. W. Kurz [Norvège]The role of APOE alleles in incident Parkinson’s disease. The Norwegian ParkWest Study
000594 C. Vossius [Norvège] ; O. B. Nilsen [Norvège] ; J. P. Larsen [Norvège]Parkinson’s disease and hospital admissions: frequencies, diagnoses and costs
000750 G. O. Skeie [Norvège] ; B. Muller [Norvège] ; K. Haugarvoll [Norvège] ; J. P. Larsen [Norvège] ; O. B. Tysnes [Norvège]Differential effect of environmental risk factors on postural instability gait difficulties and tremor dominant Parkinson's disease
000786 I. Leiknes [Norvège] ; O. Tysnes [Norvège] ; D. Aarsland [Norvège] ; J. P. Larsen [Norvège]Caregiver distress associated with neuropsychiatric problems in patients with early Parkinson’s disease: the Norwegian ParkWest study
000810 O. Tysnes [Norvège] ; B. Müller [Norvège] ; J. P. Larsen [Norvège]Are dysautonomic and sensory symptoms present in early Parkinson’s disease?
000999 C. Vossius ; O. B. Nilsen [Norvège] ; J. P. LarsenParkinson’s disease and nursing home placement: the economic impact of the need for care
001206 M. Horstink [Pays-Bas] ; E. Tolosa [Espagne] ; U. Bonuccelli [Italie] ; G. Deuschl [Allemagne] ; A. Friedman [Pologne] ; P. Kanovsky [République tchèque] ; J. P. Larsen [Norvège] ; A. Lees [Royaume-Uni] ; W. Oertel [Allemagne] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; C. Sampaio [Portugal]Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society–European Section. Part I: early (uncomplicated) Parkinson's disease
001207 M. Horstink [Pays-Bas] ; E. Tolosa [Espagne] ; U. Bonuccelli [Italie] ; G. Deuschl [Allemagne] ; A. Friedman [Pologne] ; P. Kanovsky [République tchèque] ; J. P. Larsen [Norvège] ; A. Lees [Royaume-Uni] ; W. Oertel [Allemagne] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; C. Sampaio [Portugal]Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society‐European Section (MDS‐ES). Part II: late (complicated) Parkinson's disease
001242 A. M. Schlitter [Allemagne] ; M. Kurz [Allemagne, Norvège] ; J. P. Larsen [Norvège] ; D. Woitalla [Allemagne] ; T. Müller [Allemagne] ; J. T. Epplen [Allemagne] ; G. Dekomien [Allemagne]Parkin gene variations in late‐onset Parkinson's disease: comparison between Norwegian and German cohorts
001318 C. Vossius [Norvège] ; M. Gjerstad [Norvège] ; H. Baas [Allemagne] ; J. P. Larsen [Norvège]Drug costs for patients with Parkinson's disease in two different European countries
001404 K. Haugarvoll [Norvège] ; D. Aarsland [Norvège] ; T. Wentzel-Larsen [Norvège] ; J. P. Larsen [Norvège]The influence of cerebrovascular risk factors on incident dementia in patients with Parkinson's disease
001695 K. Herlofson [Norvège] ; J. P. Larsen [Norvège]The influence of fatigue on health‐related quality of life in patients with Parkinson's disease
001769 M. Kurz ; G. Alves ; D. Aarsland [Norvège] ; J. P. LarsenFamilial Parkinson's disease: a community‐based study
001B01 M. K. Beyer ; K. Herlofson ; D. Rsland [Norvège] ; J. P. LarsenCauses of death in a community‐based study of Parkinson's disease
001D66 D. Aarsland [Norvège] ; J. P. Larsen [Norvège] ; K. Karlsen [Norvège] ; N. G. Lim [Norvège] ; E. Tandberg [Norvège]Mental symptoms in Parkinson's disease are important contributors to caregiver distress
002033 V. V. Myllyl [Finlande] ; M. Jackson [Royaume-Uni] ; J. P. Larsen [Norvège] ; H. Baas [Allemagne]Efficacy and safety of tolcapone in levodopa‐treated Parkinson's disease patients with “wearing‐off” phenomenon: a multicentre, double‐blind, randomized, placebo‐controlled trial
002448 J. P. Larsen [Norvège] ; E. Dupont [Danemark] ; E. Tandberg [Norvège]Clinical diagnosis of Parkinson's disease. Proposal of diagnostic subgroups classified at different levels of confidence

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024